Though losing at EBIT level, Hua Medicine (Shanghai) maintai...
Though losing at EBIT level, Hua Medicine (Shanghai) maintains a positive free cash flow. Concern arises from its modest revenue growth and potential risks affecting its stock.
Is Hua Medicine (Shanghai) (HKG:2552) Using Debt In A Risky Way?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4575Followers
0Following
9994Visitors
Follow